Top
TATDN2 has not been detected as a mutational cancer driver

TATDN2
Ensembl id ENSG00000157014
Mutated samples
Coding Sequence 43 (0.6%)
Protein Affecting 20 (0.3%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all TATDN2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 11 6 1.63
Uterine corpus endometrioid carcinoma No 6 3 1.30
Lung squamous cell carcinoma No 2 2 1.15
Colorectal adenocarcinoma No 2 2 0.87
Lung adenocarcinoma No 2 1 0.26
Bladder carcinoma No 1 1 1.02
Pancreas adenocarcinoma No 1 1 0.47
Stomach adenocarcinoma No 1 1 0.62
Small cell lung carcinoma No 1 1 1.45
Head and neck squamous cell carcinoma No 2 1 0.27
Esophageal carcinoma No 2 1 0.68
Prostate adenocarcinoma No 1 0 0.00
Breast carcinoma No 4 0 0.00
Renal clear cell carcinoma No 1 0 0.00
Neuroblastoma No 1 0 0.00
Chronic lymphocytic leukemia No 1 0 0.00
Lower grade glioma No 1 0 0.00
Serous ovarian adenocarcinoma No 1 0 0.00
Glioblastoma multiforme No 2 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence